FY2025
(March 1,2025-February 28,2026)

• Consolidated Financial Results for the Nine Months Ended November 30, 2025（PDF file/293KB）
• Supplementary Financial Data(March 1, 2025 to November 30, 2025)（PDF file/322KB）
• Notice Regarding Share Transfer of Equity Method Affiliate and Recording of Extraordinary Gains（PDF file/250KB）
• Notice Regarding Revision of Full-Year Consolidated Earnings Forecast（PDF file/133KB）
• Notice Regarding Changes in Equity Method Affiliates (Share Transfer) and Recording of Extraordinary Gains（PDF file/133KB）
• Notice on Recording of Gain on Sale of Investment Securities（PDF file/125KB）
• Notice on Sale of Investment Securities（PDF file/119KB）
• Consolidated Financial Results for the Six Months Ended August 31, 2025（PDF file/455KB）
• Supplementary Financial Data(Marchi 1,2025 to August 31,2025（PDF file/312KB）
• Earnings Presentation for the Six Months Ended August 31, 2025（PDF file/3MB）
• Update on Efforts to Adopt Capital Cost- and Share Price-Conscious Management（PDF file/596KB）
• Consolidated Financial Results for the Three Months Ended May,31 2025（PDF file/290KB）
• Supplementary Financial Data(March 1,2025 to May 31,2025)（PDF file/482KB）
• Notice on Recording of Extraordinary Losses（PDF file/220KB）
• Notice of Absorption_Type Merger (Simplified MergerShort Form Merger) of Consolidated Subsidiary and Waiver of Claims（PDF file/259KB）
• Notice Concerning Controlling Shareholders（PDF file/166KB）
• FY2024 Evaluation Results on the Effectiveness of the Board of Directors（PDF file/186KB）